Publications

Year of Publicationsort descending Title Faculty Association
2022 Editorial: Chronic orofacial pain. Frank Porreca, PhD
2022 Age and sex differences on anti-hyperglycemic medication exposure and risk of newly diagnosed multiple sclerosis in propensity score matched type 2 diabetics. Roberta Diaz Brinton, Ph.D, Kathleen Rodgers, Ph.D.
2022 A tale of two systems: Lessons learned from female mid-life aging with implications for Alzheimer's prevention & treatment. Roberta Diaz Brinton, Ph.D, Kathleen Rodgers, Ph.D., Fei Yin, Ph.D.
2022 Blood-Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke. Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS
2022 Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies. Mohab M. Ibrahim, PhD, MD, Laurent F Martin
2022 Cerebral arteriolar and neurovascular dysfunction after chemically induced menopause in mice. Tally Largent-Milnes, PhD
2022 Effects of docosahexaenoic acid and eicosapentaoic acid supplementation on white matter integrity after repetitive sub-concussive head impacts during American football: Exploratory neuroimaging findings from a pilot RCT. Roberta Diaz Brinton, Ph.D
2022 EPDR1 is a noncanonical effector of insulin-mediated angiogenesis regulated by an endothelial-specific TGF-β receptor complex. Nam Lee, Ph.D.
2022 Design, Physicochemical Characterization, and In Vitro Permeation of Innovative Resatorvid Topical Formulations for Targeted Skin Drug Delivery. Sally Dickinson, Ph.D.
2022 Targeting organic cation transporters at the blood-brain barrier to treat ischemic stroke in rats. Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS
2022 High-Dose Acetaminophen Alters the Integrity of the Blood-Brain Barrier and Leads to Increased CNS Uptake of Codeine in Rats. Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD, FAAPS
2022 Targeting 5-HT receptors and Kv7 channels in PFC to attenuate chronic neuropathic pain in rats using a spared nerve injury model. Tally Largent-Milnes, PhD, Arthur Charles Riegel, Todd Vanderah, PhD
2022 Kappa Opioid Receptor Blockade in the Amygdala Mitigates Pain Like-Behaviors by Inhibiting Corticotropin Releasing Factor Neurons in a Rat Model of Functional Pain. Edita Navratilova, Frank Porreca, PhD
2022 Contributions of sex and genotype to exploratory behavior differences in an aged humanized mouse model of late-onset Alzheimer's disease. Roberta Diaz Brinton, Ph.D
2022 Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer. Nam Lee, Ph.D.
2022 Synthesis of ()()-Tiruchanduramine. Christopher Cartmell
2022 Age-Induced Changes in μ-Opioid Receptor Signaling in the Midbrain Periaqueductal Gray of Male and Female Rats. John M. Streicher, PhD
2022 Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-/Activin Receptor-Like Kinase 1 Signaling: Relevance to the Brain Disposition of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors (i.e., Statins). Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD, FAAPS
2022 Androgen-targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer. Roberta Diaz Brinton, Ph.D, Kathleen Rodgers, Ph.D.
2022 Hypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancers. Nam Lee, Ph.D.
2022 Microencapsulation and incubation methodology for the cultivation of marine bacteria. Christopher Cartmell
2022 Radiocaine: An Imaging Marker of Neuropathic Injury. Tally Largent-Milnes, PhD
2022 Inhibition of HSP90 Preserves Blood-Brain Barrier Integrity after Cortical Spreading Depression. Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, John M. Streicher, PhD
2022 Transport Mechanisms at the Blood-Brain Barrier and in Cellular Compartments of the Neurovascular Unit: Focus on CNS Delivery of Small Molecule Drugs. Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS
2022 Discovery of κ Opioid Receptor (KOR)-Selective d-Tetrapeptides with Improved Antinociceptive Effect after Peripheral Administration. John M. Streicher, PhD

Pages